Related Experiment Video
Updated: Nov 10, 2025

Investigating the Protective Effects of Platycodin D on Non-Alcoholic Fatty Liver Disease in a Palmitic Acid-Induced In Vitro Model
Published on: December 2, 2022
A PDCD1 Role in the Genetic Predisposition to NAFLD-HCC?
Nardeen Eldafashi1,2, Rebecca Darlay3, Ruchi Shukla4
1Translational and Clinical Research Institute, Faculty of Medical Sciences, The Medical School, Newcastle University, Framlington Place, Newcastle upon Tyne NE2 4HH, UK.
Genetic variations in immune response genes, specifically PDCD1, are linked to the development of liver cancer (HCC) in patients with non-alcoholic fatty liver disease (NAFLD). These findings suggest a role for immune regulation in NAFLD-HCC pathogenesis.
Area of Science:
- Genetics
- Immunology
- Hepatology
Background:
- Obesity and non-alcoholic fatty liver disease (NAFLD) are increasing global mortality from hepatocellular carcinoma (HCC).
- While hepatic steatosis, steatohepatitis, and fibrosis are key factors, altered immune responses are implicated in NAFLD-HCC pathogenesis.
- Previous genetic studies identified variants in fat-deposition genes (PNPLA3, TM6SF2) associated with liver disease progression.
Purpose of the Study:
- To investigate the association between single-nucleotide polymorphisms (SNPs) in candidate immunoregulatory genes and the development of NAFLD-HCC.
- To explore the roles of specific SNPs in immune tolerance induction in NAFLD patients.
Main Methods:
- Genotyping of SNPs in immunoregulatory genes (MICA, CD44, PDCD1) in 594 NAFLD patients and 391 NAFLD-HCC patients.
- Analysis of associations between these SNPs and clinical factors (age, BMI, diabetes, cirrhosis) with HCC development.
- Statistical analysis to determine independent associations with NAFLD-HCC risk.
Main Results:
- PNPLA3 and TM6SF2 SNPs were associated with cirrhosis progression and NAFLD-HCC development.
- PDCD1 SNPs were specifically linked to NAFLD-HCC risk, independent of cirrhosis.
- PDCD1 rs7421861 showed independent association, while rs10204525 was significant after adjusting for other risks, particularly in women.
Conclusions:
- Genetic variations in PDCD1 play a significant role in NAFLD-HCC development, irrespective of cirrhosis.
- Inter-individual differences in immune tolerance induction may impact NAFLD-HCC risk.
- These findings contribute to understanding the complex pathogenesis of NAFLD-associated liver cancer.
More Related Videos
Related Concept Videos
Coronary Artery Disease I: Introduction
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...

